Allogeneic cell therapy: The treatment of choice for all hematologic malignancies relapsing post BMT [2]

S. Slavin; E. Naparstek; A. Nagler; Y. Kapelushnik; A. Ackerstein; R. Or; H. J. Kolb

doi:10.1182/blood.v87.9.4011.bloodjournal8794011

Allogeneic cell therapy: The treatment of choice for all hematologic malignancies relapsing post BMT [2]

S. Slavin^*
, E. Naparstek
, A. Nagler
, Y. Kapelushnik
, A. Ackerstein
, R. Or
, H. J. Kolb

^*Corresponding author for this work

Hadassah University Medical Centre

Research output: Contribution to journal › Letter › peer-review

22 Scopus citations

Original language	English
Pages (from-to)	4011-4013
Number of pages	3
Journal	Blood
Volume	87
Issue number	9
DOIs	https://doi.org/10.1182/blood.v87.9.4011.bloodjournal8794011
State	Published - 1996
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1182/blood.v87.9.4011.bloodjournal8794011

Cite this

@article{ff4893469d8048bb935ce7f5a837f9b5,

title = "Allogeneic cell therapy: The treatment of choice for all hematologic malignancies relapsing post BMT [2]",

author = "S. Slavin and E. Naparstek and A. Nagler and Y. Kapelushnik and A. Ackerstein and R. Or and Kolb, \{H. J.\}",

year = "1996",

doi = "10.1182/blood.v87.9.4011.bloodjournal8794011",

language = "אנגלית",

volume = "87",

pages = "4011--4013",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "9",

}

TY - JOUR

T1 - Allogeneic cell therapy

T2 - The treatment of choice for all hematologic malignancies relapsing post BMT [2]

AU - Slavin, S.

AU - Naparstek, E.

AU - Nagler, A.

AU - Kapelushnik, Y.

AU - Ackerstein, A.

AU - Or, R.

AU - Kolb, H. J.

PY - 1996

Y1 - 1996

UR - https://www.scopus.com/pages/publications/0029875481

U2 - 10.1182/blood.v87.9.4011.bloodjournal8794011

DO - 10.1182/blood.v87.9.4011.bloodjournal8794011

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

AN - SCOPUS:0029875481

SN - 0006-4971

VL - 87

SP - 4011

EP - 4013

JO - Blood

JF - Blood

IS - 9

ER -

Allogeneic cell therapy: The treatment of choice for all hematologic malignancies relapsing post BMT [2]

UN SDGs

Access to Document

Other files and links

Cite this